Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for lisdexamfetamine

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Aug 31, 2026 · 4 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Lisdexamfetamin (ATC-Code nach WHO: N06BA12)

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

The structured data states an end date of 31.08.2026, while the XML notice change text says the open-house procedure en...

The notice refers to project-room documents ('Anschreiben', 'Erläuterungen der Vertragsbedingungen', 'Einreichungsfrist...

Submission deadline in 4 days

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2026
  • Conclusion of non-exclusive pharmaceutical rebate agreements under Section 130a(8) SGB V for the active substance lisdexamfetamine.
  • Open-house model: any interested pharmaceutical company may join during the participation period if it meets and accepts the conditions.
Pokaż pełne podsumowanie

This is an open-house supply arrangement for non-exclusive pharmaceutical rebate agreements for lisdexamfetamine (ATC N06BA12) with AOK PLUS. The procedure is open to all interested pharmaceutical companies that meet the stated participation conditions. No contract value is stated, no minimum purchase is guaranteed, and the agreement can end early if exclusive rebate agreements are concluded. Participation documents are available via DTVP, but no extracted procurement document text beyond the TED XML notice was provided.

Ryzyka

The structured data states an end date of 31.08.2026, while the XML notice change text says the open-house procedure en...

The notice refers to project-room documents ('Anschreiben', 'Erläuterungen der Vertragsbedingungen', 'Einreichungsfrist...

Submission deadline in 4 days

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only pharmaceutical undertakings within the meaning of Section 4(18) AMG for the offered medicinal products may participate.

Eligibility

  • Submit the completed declaration on the absence of exclusion grounds with the participation documents.

Administrative

  • Submit the declaration regarding Russia sanctions compliance using the provided form.

Zamawiający

Lokalizacja

Erfurt, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE256878834

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for lisdexamfetamine

Non-exclusive rebate agreement for medicines containing lisdexamfetamine (ATC N06BA12). The lot is a supply contract under an open-house model; no exclusivity, no individual negotiations, and demand/volume are unknown. Performance/place of performance is indicated as Dresden, Germany, with broader reference to Saxony and Thuringia in the notice text.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Dresden, Germany

Czas trwania

Aug 2025 - Aug 2026

Kategoria

Pharmaceutical products

Termin

Deadline Aug 31, 2026

Szczegóły zamówienia

Data publikacji
02 Dec 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
800535-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3